Medsafe

The reclassification of codeine-containing medicines will go ahead this year after the final objection to the change was determined to be invalid. 

Influencer Sera Lilly has continued to sell teas containing senna leaf, despite the herb being a pharmacy-only medicine

Promisia CEO Rene de Wit has slammed a new study examining the toxicity of a herbal extract found in the company’s natural dietary supplement Arthrem, following a reports of liver harm (hepatotoxicity)

Following a disastrous period which has seen Kiwi company Promisia Integrative prosecuted by the Ministry of Health, its flagship product banned in Australia, and falling sales, the company has revealed it’s reinventing itself

The body representing New Zealand’s fledgling medicinal cannabis industry is welcoming the long-awaited regulations that will govern the sector

Several “detox” and diet teas have been revealed to contain sennosides, a pharmacy-only medicine, and pulled from the shelves, following a Consumer NZ investigation

The Medicines Classification Committee has determined reclassifying all codeine-containing medicines to prescription-only is justified

The migraine treatment Cafergot (AFT Pharmaceuticals) will no longer be approved for use in New Zealand from May next year

Medsafe has issued a warning after a patient taking the anticoagulant dabigatran experienced vasculitis

The migraine treatment Cafergot will no longer be approved for use in New Zealand from May next year